Personalized Diagnostics in Melanoma

Lynn Schuchter, MD, Chief, Division of Hematology/Oncology at Penn Medicine presents on the benefits of personalized diagnostics and genomic testing for patients with melanoma, with a focus on BRAF mutant melanoma and BRAF/MEK inhibitor therapy, and the ways oncologists are managing acquired resistance to therapy.



Related Links



October 14, 2013

Created by

Penn Physician VideoLink